Dawnrays Pharmaceutical (Holdings) Limited Stock Price

SEHK:2348 Community·HK$1.5b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

2348 Share Price Performance

HK$1.00

-0.24 (-19.35%)

HK$1.00

-0.24 (-19.35%)

HK$1.00

Sun, 28 Jun 26

Share Pricen/a

2348 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

2 Risks

1 Reward

View Full Analysis

Dawnrays Pharmaceutical (Holdings) Limited Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 0.14
: 45.29%
: 17.38%
: 2.3%

View Full Analysis

About 2348

Founded: 1995
Employees: 1081
CEO: Liwei Yu
WebsiteView website: www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.